Technology & Engineering

Research

The Latest

Monoclonal Antibody Targets, Kills Leukemia Cells

Researchers at the University of California, San Diego Moores Cancer Center have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells.

UC San Diego Pharmacy School Benefactor “Sam” Skaggs Dies at 89

L.S. “Sam” Skaggs, whose enduring support of pharmacy education and research helped fuel the growth and development of the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego, died Thursday at the age of 89 of causes related to age.

Kidney Sparing Surgery Underutilized for Patients Who Need It Most

Researchers at the University of California, San Diego School of Medicine have released study results that show national treatment trends in the surgical management of patients with kidney disease. The study found that partial and complete kidney removal (total nephrectomy) and energy-based techniques to destroy tumors are all on the rise. Surprisingly, the patients most in need of kidney-sparing surgery are still more likely to undergo total nephrectomy.

Could a Robotic Skateboard Defeat Tony Hawk? One Day, Maybe

“Five! Four! Three! Two! One!” A robotic skateboard soared high into the air and above Paul Schmitt, a scientist and skateboard designer, then landed with a thud on the floor of the Main Gym on the UC San Diego campus on Monday, March 18.

Viewing Research Bandwidth Through A New Prism

After developing one of the most advanced research communications infrastructures on any university campus over the past decade, the University of California, San Diego is taking another leap forward in the name of enabling data-intensive science.

New Imaging Agent Enables Better Cancer Detection, More Accurate Staging

Researchers at the University of California, San Diego School of Medicine have shown that a new imaging dye, designed and developed at UC San Diego Moores Cancer Center, is an effective agent in detecting and mapping cancers that have reached the lymph nodes. The radioactive dye called Technetium Tc-99m tilmanocept, successfully identified cancerous lymph nodes and did a better job of marking cancers than the current standard dye.